1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 586 F.Supp.3d
  5. 586 F.Supp.3d 231 (2022)
 

HARRIS v. PFIZER INC.

21cv6789 (DLC).

586 F.Supp.3d 231 (2022)

Roslyn HARRIS and Mary Allen, Plaintiffs, v. PFIZER INC., Defendant.

United States District Court, S.D. New York.

Signed February 16, 2022.

Attorney(s) appearing for the Case

For plaintiffs: Andrew Obergfell , Bursor & Fisher, P.A., 888 Seventh Avenue, New York, NY 10019.

For defendant: Colleen Gulliver , Loren H. Brown , Jessica Carol Wilson , DLA Piper US LLP (NY), 1251 Avenue of the Americas, 27th Floor, New York, NY 10020.

OPINION AND ORDER

Roslyn Harris and Mary Allen bring this putative class action against Pfizer Inc. ("Pfizer") after its voluntary recall of the drug Chantix, which was found to be contaminated with excess levels of a N-nitroso-varenicline. Pfizer has moved to dismiss the complaint. For the following reasons...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases